🚨🚨Our new paper is out! We discuss the potential of nucleoside supplementation as a treatment for RRM2B.
Many thanks to all that contributed to this research!
🧬 New paper! We nudge the science forward surrounding deoxynucleoside supplementation & mitochondrial DNA depletion syndromes (MDDS). We show, for the first time in vivo, that deoxynucleoside supplementation can mitigate effects of RRM2B mutations.🔗 https://t.co/WLHSOSrhob
A 2023 Review in Science Translational Medicine looks at the complex connections between astrocytes and other types of cells in the nervous system, including neurons, oligodendrocytes, and microglia.
Learn more: https://t.co/a3vF8BPxH1 #ScienceMagArchives
🎉We are delighted to share exciting news from the uOttawa Brain and Mind Research Institute (@uOttawaBMRI) that Dr Hanns Lochmüller and Dr @MireilleKhacho have been appointed as the new leaders of the Neuromuscular Health research hub!
👨🔬We've just invested nearly £80K into a new project that could potentially alleviate symptoms for patients diagnosed with MNGIE. 👩🔬
If you'd like to read more about their research click the link below for more information. @cam_mito
https://t.co/AU9vcGe6Wl
During #mito disease awareness week the whole MitoCAMB team has come together to share knowledge, experience & ideas at our away day. Lots of fun, but also a chance to build relationships & facilitate even better research for the future! @Jellevda@HorvathLab@MRC_MBU@NellNie
💚IT'S HERE!!!!!💚
💚World Mitochondrial Disease Week Has Begun!!!💚
👀Keep your eyes peeled for some fabulous posts coming up this week!👀
🧑🤝🧑Together we can continue to raise awareness around mitochondrial disease!🧑🤝🧑
Many thanks @MDUK_News for funding our project. Very excited about the future research into amino acid supplementation of mt-aars patients
More details below:👇🏻
https://t.co/NWB4YcYE7M
Astrocytes exert both gain and loss of function pathologies in ALS, providing a dilemma in therapeutics. Prompted by our recent paper in @braincomms, we revisited our earlier works in @CommsBio + @NatureNeuro@NaturePortfolio@NatureComms at https://t.co/bbeRt8bC1R for AC lovers.
We were delighted to work with the @4Lilyfoundation & their expert patient input committee to develop a leaflet for patients diagnosed with #mito disease. It provides basic info and signposting to more resources locally and across the UK! @Jellevda@HorvathLab@MitoResearch
📢We are hiring! A Clinical Research Manager to join the friendly and enthusiastic MitoCAMB team! A really interesting and diverse job working on world-class research in #mito disease. #joinus
https://t.co/tWSHPXSfaW
@Jellevda@HorvathLab@MRC_MBU@CamNeuro@camraredisease
📢We are hiring! A Clinical Research Manager to join the friendly and enthusiastic MitoCAMB team! A really interesting and diverse job working on world-class research in #mito disease. #joinus
https://t.co/tWSHPXSfaW
@Jellevda@HorvathLab@MRC_MBU@CamNeuro@camraredisease
Congrats to @chrismutti1 on publishing his PhD research on mitoribosome assembly! This builds upon @LindseyVanHaute's work on the methyltransferase METTL15, revealing that its catalytic activity is not essential for mtSSU biogenesis. https://t.co/fexZAMz5UU @MBU_postdocs@MRC_MBU
We are delighted to announce that Hanns is this year’s winner of the Researcher of the Year award conferred by @uOttawaMed and @OttawaHospital.🥳Congratulations Hanns, your team is very proud of you!
🏆Read more about the award: https://t.co/Sr6oMq5sc2